Clinical Trial Update: Study of Sildenafil as a Therapy for Fatigue in Pancreatic Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating sildenafil for fatigue in pancreatic cancer (and cholangiocarcinoma) has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma
• Pancreatic Cancer

Drugs mentioned

• SILDENAFIL (SILDENAFIL)

Snippet

Sponsor: The University of Texas Medical Branch, Galveston | Conditions: Pancreatic Cancer, Cholangiocarcinoma | Phase 1 | Status: WITHDRAWN